CMS opens coverage analysis on oxygen for cluster headaches
This article was originally published in The Gray Sheet
Executive Summary
At the request of the American Headache Society and the American Academy of Neurology, CMS opened a national coverage analysis April 9 on home use of oxygen to treat cluster headaches. Current durable medical equipment policy on home oxygen does not address its use to treat cluster headaches, which CMS says may impact as many as 36,000 Medicare beneficiaries. According to the agency, cluster headaches may occur over many weeks, and are characterized by severe stabbing pain behind the eye, often accompanied by redness and tearing of the eye, as well as nasal congestion. Comments are due May 9
You may also be interested in...
CMS Asked To Offer Distinct Home Oxygen Coverage For Cluster Headache
Neurologists and patient advocates want CMS to update its durable medical equipment policy to cover home oxygen to treat cluster headaches
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.